Wichtige Dokumente

Gesamtdokumentation anzeigen

Fortfahren mit

1019701

USP

Amilorid -hydrochlorid

Name: Amilorid -hydrochlorid
Brand: USP
Price: 407 EUR

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

Amilorid -hydrochlorid Dihydrat, N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid -hydrochlorid Dihydrat

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern

Packungsgröße	SKU	Verfügbarkeit	Preis
500 mg		Warenkorb auf Verfügbarkeit prüfen	€ 407,00

Über diesen Artikel

Empirische Formel (Hill-System):

C₆H₈ClN₇O · HCl · 2H₂O

CAS-Nummer:

17440-83-4

Molekulargewicht:

302.12

MDL number:

MFCD11046655

UNSPSC Code:

41116107

NACRES:

NA.24

€ 407,00

Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragen

Technischer Dienst

Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.

Unterstützung erhalten

grade

pharmaceutical primary standard

API family

amiloride

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

Clc1nc(c(nc1N)N)C(=O)N\C(=N\[H])\N.Cl.O.O

InChI

1S/C6H8ClN7O.ClH.2H2O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11;;;/h(H4,8,9,13)(H4,10,11,14,15);1H;2*1H2

InChI key

LTKVFMLMEYCWMK-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel	A7410	Y0001902	1019712
USP 1019701 Amiloride hydrochloride	Sigma-Aldrich A7410 Amiloride hydrochloride hydrate	Y0001902 Amiloride for peak identification	USP 1019712 Amiloride Related Compound A
manufacturer/tradename USP	manufacturer/tradename -	manufacturer/tradename EDQM	manufacturer/tradename USP
grade pharmaceutical primary standard	grade -	grade pharmaceutical primary standard	grade pharmaceutical primary standard
application(s) pharmaceutical (small molecule)	application(s) -	application(s) -	application(s) pharmaceutical (small molecule)
format neat	format -	format neat	format neat
API family amiloride	API family -	API family amiloride	API family amiloride

General description

Amiloride hydrochloride is a photosensitive yellow powder used as a mild diuretic drug.[1]

Application

Amiloride hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Amiloride Hydrochloride and Hydrochlorothiazide Tablets
Amiloride Hydrochloride Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Comparable product

Produkt-Nr.

Beschreibung

Preisangaben

A0370000

Amiloride hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0001902

Amiloride for peak identification, European Pharmacopoeia (EP) Reference Standard

BP008

Amiloride hydrochloride, British Pharmacopoeia (BP) Reference Standard

Y0000020

Amiloride impurity A, European Pharmacopoeia (EP) Reference Standard

1019712

Amiloride Related Compound A, United States Pharmacopeia (USP) Reference Standard

BP920

Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate, British Pharmacopoeia (BP) Reference Standard

Lagerklasse

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation.

Matthias Schoenberger et al.

Expert opinion on therapeutic patents, 23(10), 1383-1389 (2013-08-21)

Novel molecular platforms for epithelial sodium channel (ENaC) modulators are claimed in the following six patents: WO2012035158(A1); WO2009074575(A2); WO2011028740(A1); WO2009150137(A2); WO2011079087(A1); WO2008135557(A1). These ENaC inhibitors may be used in blocking transepithelial sodium and consequently water absorption across airway epithelia. This

Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors.

Hector Rasgado-Flores et al.

American journal of physiology. Cell physiology, 305(11), C1114-C1122 (2013-08-30)

Hypertonic saline (HS) inhalation therapy benefits cystic fibrosis (CF) patients [Donaldson SH, Bennet WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. N Engl J Med 354: 241-250, 2006; Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks

The Na⁺/H⁺ exchanger isoform 3 is required for active paracellular and transcellular Ca²⁺ transport across murine cecum.

Juraj Rievaj et al.

American journal of physiology. Gastrointestinal and liver physiology, 305(4), G303-G313 (2013-06-15)

Intestinal calcium (Ca²⁺) absorption occurs via paracellular and transcellular pathways. Although the transcellular route has been extensively studied, mechanisms mediating paracellular absorption are largely unexplored. Unlike passive diffusion, secondarily active paracellular Ca²⁺ uptake occurs against an electrochemical gradient with water

Gamma subunit second transmembrane domain contributes to epithelial sodium channel gating and amiloride block.

Shujie Shi et al.

American journal of physiology. Renal physiology, 305(11), F1585-F1592 (2013-10-11)

The epithelial sodium channel (ENaC) is comprised of three homologous subunits. Channels composed solely of α- and β-subunits (αβ-channels) exhibit a very high open probability (Po) and reduced sensitivity to amiloride, in contrast to channels composed of α- and γ-subunits

Acute inhibition of NCC does not activate distal electrogenic Na+ reabsorption or kaliuresis.

Robert W Hunter et al.

American journal of physiology. Renal physiology, 306(4), F457-F467 (2014-01-10)

Na(+) reabsorption from the distal renal tubule involves electroneutral and electrogenic pathways, with the latter promoting K(+) excretion. The relative activities of these two pathways are tightly controlled, participating in the minute-to-minute regulation of systemic K(+) balance. The pathways are

Alle zugehörigen Dokumente anzeigen

Global Trade Item Number

SKU	GTIN
1019701-500MG	04061838668691

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung